S100P and intrahepatic cholangiocarcinoma: They proposed that ICC can be classified into S100P + SPP1− and S100P−SPP1+ ICC subtypes based on S100P and SPP1 expression and noted significant differences in clinicopathological characteristics, gene regulatory networks, and immune infiltration between these two ICC subtypes.